Dileep Kumar received his B. Pharm from Manipal College of Pharmaceutical Sciences, Manipal University, and M. Pharm from S.G.S.I.T.S Indore, Madhya Pradesh. He has several patents to his credit. He was awarded a Junior Research fellowship by National Medicinal Plant Board (NMPB) New Delhi, Senior Research Fellowship from University Grants Commission (UGC), Teaching Assistantship, and institute Post-Doctoral fellowship from IIT (BHU) Varanasi. At present, he is teaching as an assistant professor at Poona College of pharmacy, Bharti Vidyapeeth University Pune. He has published many papers and patents. He is Guest editor of several Prestigious journals. At present he is visiting professor in the department of entomology and Comprehensive Cancer Center in university of California Davis

Select Guide Rating

• 1. Reviewing recent advancements in risk- stratified early detection strategies for breast cancer, including novel screening modalities and risk assessment toolsPriya Bisht, Lokesh Nama, Krishna Murti and Nitesh Kumar2. Recent advances in the molecular pathogenesis and targeted treatment of breast cancerPalakurthi Yanadaiah, J.P. Yanadaiah and Sachin Kumar Singh3. Precision medicine approaches and the management of triple-negative breast cancerRitu Soni, Mithun Singh Rajput and Jigna Shah4. Multigene assays for prognosis and prediction in breast cancerBhavna Bohra, Richa Gupta and Bhagawati Saxena5. Recent progress in immunotherapy and vaccine development for breast malignanciesAnjali Suryavanshi, Pragya Gupta, Meenakshi Jaiswal, Sanmati Kumar Jain, Karthikeyan Kesavan, Dileep Kumar and Sanjay Kumar Bharti6. Emerging imaging biomarkers for screening, staging, and treatment response in breast cancerSiddhant Tripathi, Yashika Sharma and Dileep Kumar7. Advancements in risk-stratified early detection strategies for breast cancerViswapriya Viswalingam and Dileep Kumar8. Innovations in oncoplastic and reconstructive techniques post breast cancer therapySiddhant Tripathi, Yashika Sharma and Dileep Kumar9. CDK4/6 inhibitors for the treatment of breast cancerSharma Ayush, Patel Snehal, Rajput Mithun Singh and Dileep Kumar10. Disparities in breast cancer incidence, diagnosis, and outcomes: current status and future directionsViswapriya Viswalingam and Dileep Kumar11. Elucidating mechanisms of endocrine resistance in estrogen receptor-positive breast cancerViswapriya Viswalingam and Dileep Kumar12. Metastatic breast cancer in the era of targeted systemic and localized therapiesSiddhant Tripathi, Yashika Sharma and Dileep Kumar13. Mitigating treatment-related toxicity in breast cancer managementSiddhant Tripathi, Yashika Sharma and Dileep Kumar14. Multimodal therapies for residual, recurrent, and metastatic breast cancerSachin Shetty, Rajat Hegde, Amir H Fathi, Gahan Krishna Bhat and Shama Prasada Kabekkodu

Dileep Kumar received his B. Pharm from Manipal College of Pharmaceutical Sciences, Manipal University, and M. Pharm from S.G.S.I.T.S Indore, Madhya Pradesh. He has several patents to his credit. He was awarded a Junior Research fellowship by National Medicinal Plant Board (NMPB) New Delhi, Senior Research Fellowship from University Grants Commission (UGC), Teaching Assistantship, and institute Post-Doctoral fellowship from IIT (BHU) Varanasi. At present, he is teaching as an assistant professor at Poona College of pharmacy, Bharti Vidyapeeth University Pune. He has published many papers and patents. He is Guest editor of several Prestigious journals. At present he is visiting professor in the department of entomology and Comprehensive Cancer Center in university of California Davis

Select Guide Rating

• 1. Reviewing recent advancements in risk- stratified early detection strategies for breast cancer, including novel screening modalities and risk assessment toolsPriya Bisht, Lokesh Nama, Krishna Murti and Nitesh Kumar2. Recent advances in the molecular pathogenesis and targeted treatment of breast cancerPalakurthi Yanadaiah, J.P. Yanadaiah and Sachin Kumar Singh3. Precision medicine approaches and the management of triple-negative breast cancerRitu Soni, Mithun Singh Rajput and Jigna Shah4. Multigene assays for prognosis and prediction in breast cancerBhavna Bohra, Richa Gupta and Bhagawati Saxena5. Recent progress in immunotherapy and vaccine development for breast malignanciesAnjali Suryavanshi, Pragya Gupta, Meenakshi Jaiswal, Sanmati Kumar Jain, Karthikeyan Kesavan, Dileep Kumar and Sanjay Kumar Bharti6. Emerging imaging biomarkers for screening, staging, and treatment response in breast cancerSiddhant Tripathi, Yashika Sharma and Dileep Kumar7. Advancements in risk-stratified early detection strategies for breast cancerViswapriya Viswalingam and Dileep Kumar8. Innovations in oncoplastic and reconstructive techniques post breast cancer therapySiddhant Tripathi, Yashika Sharma and Dileep Kumar9. CDK4/6 inhibitors for the treatment of breast cancerSharma Ayush, Patel Snehal, Rajput Mithun Singh and Dileep Kumar10. Disparities in breast cancer incidence, diagnosis, and outcomes: current status and future directionsViswapriya Viswalingam and Dileep Kumar11. Elucidating mechanisms of endocrine resistance in estrogen receptor-positive breast cancerViswapriya Viswalingam and Dileep Kumar12. Metastatic breast cancer in the era of targeted systemic and localized therapiesSiddhant Tripathi, Yashika Sharma and Dileep Kumar13. Mitigating treatment-related toxicity in breast cancer managementSiddhant Tripathi, Yashika Sharma and Dileep Kumar14. Multimodal therapies for residual, recurrent, and metastatic breast cancerSachin Shetty, Rajat Hegde, Amir H Fathi, Gahan Krishna Bhat and Shama Prasada Kabekkodu

Dileep Kumar received his B. Pharm from Manipal College of Pharmaceutical Sciences, Manipal University, and M. Pharm from S.G.S.I.T.S Indore, Madhya Pradesh. He has several patents to his credit. He was awarded a Junior Research fellowship by National Medicinal Plant Board (NMPB) New Delhi, Senior Research Fellowship from University Grants Commission (UGC), Teaching Assistantship, and institute Post-Doctoral fellowship from IIT (BHU) Varanasi. At present, he is teaching as an assistant professor at Poona College of pharmacy, Bharti Vidyapeeth University Pune. He has published many papers and patents. He is Guest editor of several Prestigious journals. At present he is visiting professor in the department of entomology and Comprehensive Cancer Center in university of California Davis

Select Guide Rating

• 1. Reviewing recent advancements in risk- stratified early detection strategies for breast cancer, including novel screening modalities and risk assessment toolsPriya Bisht, Lokesh Nama, Krishna Murti and Nitesh Kumar2. Recent advances in the molecular pathogenesis and targeted treatment of breast cancerPalakurthi Yanadaiah, J.P. Yanadaiah and Sachin Kumar Singh3. Precision medicine approaches and the management of triple-negative breast cancerRitu Soni, Mithun Singh Rajput and Jigna Shah4. Multigene assays for prognosis and prediction in breast cancerBhavna Bohra, Richa Gupta and Bhagawati Saxena5. Recent progress in immunotherapy and vaccine development for breast malignanciesAnjali Suryavanshi, Pragya Gupta, Meenakshi Jaiswal, Sanmati Kumar Jain, Karthikeyan Kesavan, Dileep Kumar and Sanjay Kumar Bharti6. Emerging imaging biomarkers for screening, staging, and treatment response in breast cancerSiddhant Tripathi, Yashika Sharma and Dileep Kumar7. Advancements in risk-stratified early detection strategies for breast cancerViswapriya Viswalingam and Dileep Kumar8. Innovations in oncoplastic and reconstructive techniques post breast cancer therapySiddhant Tripathi, Yashika Sharma and Dileep Kumar9. CDK4/6 inhibitors for the treatment of breast cancerSharma Ayush, Patel Snehal, Rajput Mithun Singh and Dileep Kumar10. Disparities in breast cancer incidence, diagnosis, and outcomes: current status and future directionsViswapriya Viswalingam and Dileep Kumar11. Elucidating mechanisms of endocrine resistance in estrogen receptor-positive breast cancerViswapriya Viswalingam and Dileep Kumar12. Metastatic breast cancer in the era of targeted systemic and localized therapiesSiddhant Tripathi, Yashika Sharma and Dileep Kumar13. Mitigating treatment-related toxicity in breast cancer managementSiddhant Tripathi, Yashika Sharma and Dileep Kumar14. Multimodal therapies for residual, recurrent, and metastatic breast cancerSachin Shetty, Rajat Hegde, Amir H Fathi, Gahan Krishna Bhat and Shama Prasada Kabekkodu